<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02825264</url>
  </required_header>
  <id_info>
    <org_study_id>ISM03</org_study_id>
    <nct_id>NCT02825264</nct_id>
  </id_info>
  <brief_title>STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program</brief_title>
  <official_title>STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program in a Real-World Patient Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>iSTAR Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>iSTAR Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      STARflo is a novel suprachoroidal Glaucoma Drainage Device (GDD), bleb-free, exhibiting
      anti-fibrotic properties. Release of this CE Marked implant has been limited to leading
      Glaucoma Centers in Europe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Clinical Experience Program is being initiated to expand the surgical and clinical
      practice knowledge about the use of STARflo for reducing intraocular pression (IOP) in
      patients suffering from open angle glaucoma in a real world population of patients.

      This program is designed to be an international multicenter observational study.

      Patient data may be collected retrospectively and/or prospectively for up to 5 years after
      surgery.

      The aim of this program is to document the patient's benefit following implantation of the
      STARflo implant in a real-word patient population, to learn about surgical practices and to
      collect data to support future cost-effectiveness analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of intraocular pressure (IOP)</measure>
    <time_frame>at 12 Months</time_frame>
    <description>IOP reduction compared after 12 months compared to baseline IOP</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurence of Ocular Adverse Events</measure>
    <time_frame>up to 60 Months after surgery</time_frame>
    <description>to record and document all complications and Adverse Events/Adverse Device Effects occurred during and after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of intraocular pressure (IOP) over time</measure>
    <time_frame>at 6, 24, 36, 48 and 60 Months</time_frame>
    <description>IOP reduction compared after 6, 24, 36, 48 and 60 months compared to baseline IOP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of IOP lowering medication</measure>
    <time_frame>at 6, 12, 24, 36, 48 and 60 Months</time_frame>
    <description>Reduction of IOP lowering medication intake compare to baseline</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>STARflo</arm_group_label>
    <description>Patients who have been implanted with STARflo implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STARflo Implant</intervention_name>
    <description>All patients who have been implanted with STARflo implant from 2011 will be offered to participate to this data collection</description>
    <arm_group_label>STARflo</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from open angle glaucoma or some case of narrow angle glaucoma who have
        been implanted with STARflo.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients suffering from open angle glaucoma or some case of narrow angle glaucoma who
             have been implanted with STARflo implant from 2011

          -  Patients who have signed a Data Release form

        Exclusion criteria:

          -  Patients who did not sign a Data Release form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zubair Hussain, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Sponsor Representative</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Kroker, PhD</last_name>
    <phone>+49 1608548809</phone>
    <email>annek@istarmed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bât. BC-3 OPHTALMOLOGIE - POLICLINIQUE C.H.U.</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de la Croix-Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHNO des Quinze-Vingts</name>
      <address>
        <city>Paris</city>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHNO des Quinze-Vingts</name>
      <address>
        <city>Paris</city>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Baudouin, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Johannes Hospital Dortmund</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Kohlhaas, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäts-Augenklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Hirneiß, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Augenklinik Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Elisabeth Academic Hospital</name>
      <address>
        <city>Sopron</city>
        <zip>9400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>July 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2016</study_first_posted>
  <last_update_submitted>October 16, 2017</last_update_submitted>
  <last_update_submitted_qc>October 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma Drainage Device</keyword>
  <keyword>STARflo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

